Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

Methylenedioxybenzylpiperazine

From Wikipedia, the free encyclopedia
(Redirected from MDBZP)
MDBZP
Clinical data
Other names1-(3,4-Methylenedioxybenzyl)piperazine; MDBZP; MDBP; Piperonylpiperazine; N-Piperonylpiperazine
ATC code
  • None
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
Identifiers
  • 1-(Benzo[1,3]dioxol-5-ylmethyl)piperazine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.046.319 Edit this at Wikidata
Chemical and physical data
FormulaC12H16N2O2
Molar mass220.272 g·mol−1
3D model (JSmol)
  • c1cc2c(cc1CN3CCNCC3)OCO2
  • InChI=1S/C12H16N2O2/c1-2-11-12(16-9-15-11)7-10(1)8-14-5-3-13-4-6-14/h1-2,7,13H,3-6,8-9H2 X markN
  • Key:NBOOZXVYXHATOW-UHFFFAOYSA-N X markN
 X markNcheckY (what is this?)  (verify)

MDBZP, also known as 1-(3,4-methylenedioxybenzyl)piperazine or as piperonylpiperazine, is a chemical compound of the benzylpiperazine family related to benzylpiperazine (BZP). MDBZP has been sold as a designer drug[1] and has even been found as an ingredient in street Ecstasy pills.[citation needed]

See also

[edit]

References

[edit]
  1. Maurer HH, Kraemer T, Springer D, Staack RF (April 2004). "Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis". Therapeutic Drug Monitoring. 26 (2): 127–31. doi:10.1097/00007691-200404000-00007. PMID 15228152. S2CID 9255084.
[edit]